With the life sciences industry's ever-changing landscape, various risks and challenges that could impact the company's intangible assets may potentially arise. Thus, ensuring intellectual property (IP) due diligence is an imperative. Failure to provide a strategic life sciences IP due diligence might lead to an intolerable cost and a profound effect on the business’ operation and reputation; thus, companies must revisit their existing IP due diligence to ensure efficiency and effectiveness.
Our panel of key thought leaders and practitioners brought together by The Knowledge Group will offer a discussion of the fundamentals as well as updates regarding the latest and significant issues in the life sciences IP due diligence. Speakers will provide an in-depth analysis of the critical risk issues and opportunities surrounding the topic and present best practices to avoid potential liabilities.
This LIVE webcast will discuss the following key provisions:
- Life Sciences IP Due Diligence: An Overview
- Significant Trends and Developments
- Emerging Critical Issues
- IP Due Diligence Best Practices
- What Lies Ahead